These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16933265)

  • 1. A review of anti-D treatment of childhood idiopathic thrombocytopenic purpura.
    Kjaersgaard M; Hasle H
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):717-20. PubMed ID: 16933265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous anti-D treatment of idiopathic thrombocytopenic purpura in children.
    Kjaersgaard M; Edslev PW; Hasle H
    Pediatr Blood Cancer; 2009 Dec; 53(7):1315-7. PubMed ID: 19722275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cost-utility analysis of treatment for acute childhood idiopathic thrombocytopenic purpura (ITP).
    O'Brien SH; Ritchey AK; Smith KJ
    Pediatr Blood Cancer; 2007 Feb; 48(2):173-80. PubMed ID: 16550529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard-dose intravenous anti-D immunoglobulin versus intravenous immunoglobulin in the treatment of newly diagnosed childhood primary immune thrombocytopenia.
    Papagianni A; Economou M; Tragiannidis A; Karatza E; Tsatra I; Gombakis N; Athanassiadou-Piperopoulou F; Athanasiou-Metaxa M
    J Pediatr Hematol Oncol; 2011 May; 33(4):265-9. PubMed ID: 21516022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children.
    Freiberg A; Mauger D
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):23-7. PubMed ID: 9523746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children.
    Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ;
    J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and response to intravenous anti-D immunoglobulin in chronic idiopathic thrombocytopenic purpura.
    Ramadan KM; El-Agnaf M
    Clin Lab Haematol; 2005 Aug; 27(4):267-9. PubMed ID: 16048495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of anti-D in chronic idiopathic thrombocytopenic purpura.
    Yaprak I; Cağlayan S; Kansoy S; Ozdoğru E; Bakiler AR; Aydinlioğlu H
    Turk J Pediatr; 1994; 36(1):43-7. PubMed ID: 8191607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Durable response to a single dose of Anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection.
    Hewamana S; Pepper C; Karunanithi K; Jenkins C; Rowntree C
    Ann Hematol; 2009 Nov; 88(11):1155-6. PubMed ID: 19399500
    [No Abstract]   [Full Text] [Related]  

  • 11. Replacement of intravenous administration of anti-D by subcutaneous administration in patients with autoimmune thrombocytopenia.
    Meyer O; Kiesewetter H; Hermsen M; Petriedes P; Rose M; Seibt H; Salama A
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):721-2. PubMed ID: 16933269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experiences with anti-Rhesus-D therapy in pretreated patients with idiopathic thrombocytopenia].
    Pfeilstöcker M; Waldner R; Reisner R; Heinz R; Pittermann E
    Infusionsther Transfusionsmed; 1995 Aug; 22(4):220-4. PubMed ID: 7496120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal response to 100 microg/kg anti-Rh(D) in two patients who had suboptimal responses to 75 microg/kg anti-Rh(D).
    Varma M; Beautyman EJ; Grossbard ML
    Am J Hematol; 2009 Feb; 84(2):124. PubMed ID: 19051329
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-D immunoglobulin in children with newly diagnosed immune thrombocytopenic purpura: a pilot study.
    Monteleone PM; Vander Heyden MA; Steele DA; Kelleher JF
    Haematologica; 2000 Aug; 85(8):887-8. PubMed ID: 10942950
    [No Abstract]   [Full Text] [Related]  

  • 15. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
    Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
    J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute immune (idiopathic) thrombocytopenic purpura in childhood.
    Tarantino MD
    Blood Rev; 2002 Mar; 16(1):19-21. PubMed ID: 11913988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the effects of and earliest response rate to anti-D treatment in children with chronic idiopathic thrombocytopenic purpura: a pilot study.
    Yetgin S; Aytaç S; Olcay L; Tunç B; Ozbek N; Aydinok Y
    Turk J Pediatr; 2010; 52(2):126-31. PubMed ID: 20560246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. After eight-year-tolerance minimal i.v. anti-D infusions unleash hemolysis in a patient with immune thrombocytopenic purpura (ITP).
    Rewald MD; Francischetti MM
    Transfus Apher Sci; 2004 Apr; 30(2):105-10. PubMed ID: 15062747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.